Julie McElrath, M.D., Ph.D. is Senior Vice President and a full member of the Fred Hutchinson Cancer Research Center (FHCRC), where she serves as the Director of the Vaccine and Infectious Disease Division. She is also a Professor of Medicine at the University of Washington and attends on the Infectious Disease Clinical Service at FHCRC, Seattle Cancer Care Alliance and the University of Washington.
Dr. McElrath's research pursues a vaccine that will protect against HIV-1 infection and investigates how components of T-cell immunity elicited early in HIV-1 infection contribute to control of HIV-1 disease, how antigen-specific mucosal T cells protect against HIV-1 exposure, and what elements of immunity correlate with protection against HIV-1 infection by vaccine.
Dr. McElrath is PI of the Seattle Vaccine Trials Unit and the HVTN Laboratory Center. She has led the development and expansion of its operations and the GCLP laboratory program to become a highly recognized resource to the HIV vaccine field and beyond.